Michael Gelband’s Select Medical SEM Stock Holding History

Michael Gelband’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-405,190	Closed	-$5.2M	–	2009
2025 Q3	$5.2M	Buy	+405,190	New	+$5.4M	0.05%	401
2024 Q2	–	Sell	-39,299	Closed	-$638K	–	1937
2024 Q1	$638K	Sell	39,299 -157,994	-80%	-$2.31M	﹤0.01%	1079
2023 Q4	$2.5M	Buy	197,293 +143,558	+267%	+$1.81M	0.02%	513
2023 Q3	$732K	Buy	53,735 +20,730	+63%	+$320K	0.01%	1086
2023 Q2	$567K	Buy	+33,005	New	+$511K	﹤0.01%	1307
2022 Q1	–	Sell	-138,214	Closed	-$2.19M	–	2624
2021 Q4	$2.19M	Buy	+138,214	New	+$2.36M	0.02%	722
2021 Q2	–	Sell	-96,000	Closed	-$1.76M	–	2748
2021 Q1	$1.76M	Buy	+96,000	New	+$1.57M	0.03%	621

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Michael Gelband's SEM Position: Q4 2025 in Review

Michael Gelband sold out of Select Medical (SEM) in Q4 2025, closing a stake of 405,190 shares — an estimated $5.2M sold.

Michael Gelband first reported a position in SEM in Q1 2021 and held it in 7 quarters. The position peaked at $5.2M in Q3 2025. 268 funds tracked by Wall St. Rank hold SEM as of Q4 2025.

Michael Gelband reported no remaining Select Medical position as of Q4 2025 after selling out during the quarter.
Michael Gelband sold 405,190 Select Medical shares in Q4 2025, an estimated $5.2M.
Michael Gelband first reported a position in Select Medical in Q1 2021 and held it in 7 quarters.
Michael Gelband's Select Medical position peaked at $5.2M in Q3 2025.
268 funds tracked by Wall St. Rank held Select Medical as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.